Description
400 Mg Hydroxychloroquine Tablets IP Specification
- Drug Type
- General Medicines
- Physical Form
- Tablets
- Dosage
- 400 mg
- Suitable For
- Adults
- Quantity
- 1 X 10 Strip
- Storage Instructions
- Room Temperature
400 Mg Hydroxychloroquine Tablets IP Trade Information
- Minimum Order Quantity
- 100 Boxes
- Payment Terms
- Cash in Advance (CID)
- Supply Ability
- 1000 Boxes Per Month
- Delivery Time
- 5-7 Days
- Main Domestic Market
- All India
About 400 Mg Hydroxychloroquine Tablets IP
400 Mg Hydroxychloroquine Tablets IP are a type of general medicine suitable for adults. These tablets come in a physical form of tablets and have a dosage of 400 mg per tablet. The tablets are recommended to be stored at room temperature and come in a quantity of one strip containing ten tablets. Hydroxychloroquine is an antimalarial drug that is also used to treat autoimmune conditions such as rheumatoid arthritis and lupus. These tablets work by reducing inflammation in the body and suppressing the immune system.
FAQs of 400 Mg Hydroxychloroquine Tablets IP:
Q: What is the recommended dosage of Hydroxychloroquine Tablets IP?
A: The recommended dosage of Hydroxychloroquine Tablets IP is one tablet of 400 mg per day.
Q: What are the common side effects of taking Hydroxychloroquine Tablets IP?
A: Common side effects of Hydroxychloroquine Tablets IP include nausea, vomiting, headache, dizziness, and diarrhea.
Q: Can Hydroxychloroquine Tablets IP be taken during pregnancy or breastfeeding?
A: It is not recommended to take Hydroxychloroquine Tablets IP during pregnancy or while breastfeeding without consulting a doctor.
Q: Can Hydroxychloroquine Tablets IP be used to treat COVID-19?
A: The use of Hydroxychloroquine Tablets IP in treating COVID-19 is still under investigation and should only be taken under medical supervision.
Q: How should Hydroxychloroquine Tablets IP be stored?
A: Hydroxychloroquine Tablets IP should be stored at room temperature, away from moisture and direct sunlight.
Reviews
There are no reviews yet.